Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 Next >
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
Tags Breaking News: Earnings Biotechnology US: News
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Business News Biogen Inc Restaurant Brands International Inc
From CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Tags Science Health care industry Eisai Co Ltd
From CNBC.com News
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
Tags Breaking News: Earnings Breaking news Health care industry
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags Investment strategy PRO: Playbooks Advanced Micro Devices Inc
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Pfizer Inc Peloton Interactive Inc Technology
From CNBC.com News
Thursday's big stock stories: What's likely to move the market in the next trading session
Tags WABTEC CORP DRN Biogen Inc Stock markets
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Technology Tesla Inc Eisai Co Ltd
From CNBC.com News
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
Tags Business Breaking News: Business Eisai Co Ltd
From CNBC.com News
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
Tags Breaking News: Business Earnings Business
From CNBC.com News
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
Tags Biotech and Pharmaceuticals Eisai Co Ltd Breaking News: Business
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Companies Eli Lilly and Co US: News
From CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
Tags Biotechnology US: News Eli Lilly and Co
From CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
Tags Business News Biogen Inc Stock markets
From CNBC.com News
Cramer's Lightning Round: Bank of America is a buy
Tags Investment strategy Bank of America Corp Market Outlook
From CNBC.com News
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
Tags US: News Companies Biotechnology
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Business News Roku Inc International Business Machines Corp
From CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
Tags Biogen Inc Health & Science Business News
From CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
Tags Health care industry Science Healthy Returns
From CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
Tags Breaking news Health care industry Biotech and Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Restaurant Brands International Inc Airbnb Inc Lyft Inc
From CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
Tags Biotech and Pharmaceuticals Business Eisai Co Ltd
From CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Tags Biotechnology Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
5 things to know before the stock market opens Monday
Tags MGM Resorts International Business Walt Disney Co
From CNBC.com News
More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
Tags Companies US: News Biotechnology
From CNBC.com News
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
Tags Companies US: News Depression
From CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
Tags Procter & Gamble Co AstraZeneca PLC Breaking News: Markets
From CNBC.com News
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
Tags Progressive Corp Stock markets MSCI Inc
From CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
Tags US: News Companies Biotechnology
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Economy Eli Lilly and Co Investing
From CNBC.com News
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.